治験レーダーAI | ||
|---|---|---|
治験 NCT06083324 (EXERT-C)（対象：癌）は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
フィルター基準に一致する試験が1件見つかりました
タイル表示
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer (EXERT-C)
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます！「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT06083324 (EXERT-C) は 観察研究 臨床試験 で、癌 に関するものです。現在は 募集中 で、2023年2月3日 から開始しています。100 名の参加者 の募集が計画されています。この治験は Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) によって主催され、2026年1月26日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2025年2月21日 です。
概要
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
公式タイトル
EXERT-C: Prospective Study of an EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
疾患／病気
癌刊行物
この臨床試験について発表された科学記事と研究論文：その他の研究識別子
- EXERT-C
- 2023-021-SG
NCT番号
開始日
2023-02-03
最終更新日
2025-02-21
終了予定日
2026-01-26
目標参加者数
100
試験の種類
観察研究
状況
募集中
キーワード
exercise
resistance training
resistance training
群（アーム）／介入
| 参加グループ/群 | 介入/治療法 |
|---|---|
General cancer patients All patients undergoing treatment for cancer on an exercise regimen | Dose Escalated Resistance Training All individuals will be engaging in resistance training during and/or after their cancer treatment |
Head and neck cancer patients All patients undergoing treatment for head and neck cancer on an exercise regime | Dose Escalated Resistance Training All individuals will be engaging in resistance training during and/or after their cancer treatment |
Colorectal cancer patients All patients undergoing treatment for colorectal cancer on an exercise regime | Dose Escalated Resistance Training All individuals will be engaging in resistance training during and/or after their cancer treatment |
Pancreatic cancer patients All patients undergoing treatment for pancreatic cancer on an exercise regime | Dose Escalated Resistance Training All individuals will be engaging in resistance training during and/or after their cancer treatment |
Metastatic breast cancer patients All patients undergoing treatment for metastatic breast cancer on an exercise regime | Dose Escalated Resistance Training All individuals will be engaging in resistance training during and/or after their cancer treatment |
主要評価項目
副次評価項目
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months |
Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound | Measurement via ultrasound and calculation with Jackson-Pollack calculations | 3 months |
Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months |
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen | Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen | 3 months |
Determine changes in Y-balance score for each leg | Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk. | 3 months |
Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen | Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise | 3 months |
Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen | EQ-5D asks 5 questions rates from 1-5 and an overall rating of health | 3 months |
適格基準
対象年齢
成人, 高齢者
試験の最低年齢
20 Years
対象性別
全て
- Age 20-89 years
- Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study.
- Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI
- Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel.
- Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere
1. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)責任者
Colin Champ, MD, 研究責任者, Radiation Oncologist, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
試験中央連絡先
連絡先: Samantha Campbell, (412) 330-6151, [email protected]
1 1カ国の場所
Pennsylvania
AHN CI Exercise Oncology and Resiliency Center, Pittsburgh, Pennsylvania, 15202, United States
Colin E Champ, MD, CSCS, 連絡先, 412-734-7605, [email protected]
Chris Peluso, BS, 副研究者
募集中